NEW YORK--(BUSINESS WIRE)--Oct 30, 2025--

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tvardi Therapeutics, Inc. (NASDAQ: TRVD) resulting from allegations that Tvardi Therapeutics may have issued materially misleading business information to the investing public.

So What: If you purchased Tvardi Therapeutics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=46826 or call Phillip Kim, Esq. toll-free at 866-767-3653 or

See Full Page